tldrdailynews.com logo

"New Obesity and Diabetes Drug Could Revolutionize Weight Loss Market"

1 min read
Source: Financial Times
TL;DR

Eli Lilly is seeking FDA approval for a new obesity drug that could disrupt the weight loss market. The drug, tirzepatide, has shown promising results in clinical trials, with patients losing an average of 14.9% of their body weight. If approved, tirzepatide could compete with other weight loss drugs on the market and potentially become a blockbuster drug for Eli Lilly.

Topics:businesshealth#eli-lilly#fda-approval#health#market-disruption#obesity-drug#weight-loss
Share this article
  1. Eli Lilly to seek obesity drug approval that could disrupt weight loss market  Financial Times
  2. Powerful new obesity drug poised to upend weight loss care  Yahoo News
  3. Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds  CNBC
  4. Diabetes drug tested for weight loss could be game changer  Fox Business
  5. Popular diabetes drug Mounjaro shows weight loss results in new study  GMA

Want the full story? Read the original reporting

Read on Financial Times